OncLive® On Air

S13 Ep41: The European Approval of Mirdametinib Expands the Treatment Paradigm for NF1-Associated Plexiform Neurofibromas: With Ignacio Blanco, MD, PhD


Listen Later

In our exclusive interview, Dr Blanco discussed the significance of this regulatory milestone for a population that has historically lacked effective medical options. He reviewed the pivotal phase 2b ReNeu clinial trial (NCT03962543)that supported this decision, which enrolled both adult and pediatric patients with nonresectable PNs and evaluated clinical and radiologic response rates. Dr Blanco detailed the study’s findings, including overall response rates of 41% and 52% in the adult and pediatric populations, respectively; meaningful reductions in tumor volume; improvements in patient-reported pain and quality of life; and the favorable safety profile characterized primarily by dermatologic and gastrointestinal adverse effects.
...more
View all episodesView all episodes
Download on the App Store

OncLive® On AirBy OncLive® On Air

  • 4.2
  • 4.2
  • 4.2
  • 4.2
  • 4.2

4.2

21 ratings


More shows like OncLive® On Air

View all
Wait Wait... Don't Tell Me! by NPR

Wait Wait... Don't Tell Me!

38,580 Listeners

Marketplace Morning Report by Marketplace

Marketplace Morning Report

902 Listeners

Marketplace by Marketplace

Marketplace

8,632 Listeners

Research To Practice | Oncology Videos by Dr Neil Love

Research To Practice | Oncology Videos

111 Listeners

PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast by PVI, PeerView Institute for Medical Education

PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast

11 Listeners

JAMA Clinical Reviews by JAMA Network

JAMA Clinical Reviews

498 Listeners

ASCO Daily News by American Society of Clinical Oncology (ASCO)

ASCO Daily News

57 Listeners

The Curbsiders Internal Medicine Podcast by The Curbsiders Internal Medicine Podcast

The Curbsiders Internal Medicine Podcast

3,321 Listeners

OncoPharm by John Bossaer

OncoPharm

182 Listeners

ASCO Guidelines by American Society of Clinical Oncology (ASCO)

ASCO Guidelines

45 Listeners

Lung Cancer Considered by IASLC

Lung Cancer Considered

28 Listeners

Oncology Today with Dr Neil Love by Dr. Neil Love

Oncology Today with Dr Neil Love

61 Listeners

Two Onc Docs by Sam and Karine

Two Onc Docs

180 Listeners

Oncology Brothers: Practice-Changing Cancer Discussions by Oncology Brothers

Oncology Brothers: Practice-Changing Cancer Discussions

40 Listeners

NEJM AI Grand Rounds by NEJM Group

NEJM AI Grand Rounds

53 Listeners